Patents by Inventor Norman Eugene Cameron

Norman Eugene Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Angiotensin II antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
    Patent number: 6448280
    Abstract: This invention relates to the use of angiotensin II antagonists in treating or preventing the development of disease conditions associated with impaired neuronal conduction velocity, such as diabetic neuropathy, as well as their use in the manufacture of a medicament for use in such treatment. The invention also concerns pharmaceutical compositions containing an angiotensin II antagonist together with one or more other agents known to be of value in treating or preventing the development of disease conditions associated with impaired neuronal conduction velocity.
    Type: Grant
    Filed: January 5, 1995
    Date of Patent: September 10, 2002
    Assignee: Zeneca Limited
    Inventors: Frank Carey, Alexander Anthony Oldham, Norman Eugene Cameron, Mary Anne Cotter
  • Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor
    Patent number: 6337327
    Abstract: The invention relates to pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor, and their use in the treatment of diabetic complications such as diabetic neuropathy, diabetic retinopathy and diabetic nephropathy.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: January 8, 2002
    Assignee: Zeneca Limited
    Inventors: David Patrick Tuffin, Frank Carey, Mary Anne Cotter, Norman Eugene Cameron